Can Dasatinib (Stardax) be purchased in domestic hospitals?

Dasatinib (Dasatinib) is a broad-spectrum tyrosine kinase inhibitor used to treat certain types of leukemia. It is an oral drug commonly used to treat chronic myeloid leukemia (CML) and certain types of acute lymphoblastic leukemia (ALL), especially in patients who cannot tolerate or respond to other treatments.

Dasatinib (Dasatinib) is now officially launched in China and has been successfully included in the medical insurance system. Patients can purchase it directly in the country, and the price range is roughly between 4,000 yuan and 5,000 yuan. However, the final price and medical insurance reimbursement ratio need to be determined according to the hospital pharmacy regulations in your location. It is recommended to consult directly to obtain the most accurate information. In addition, if you consider more economical options, the price of foreign generic drugs of Dasatinib (Startax) is relatively affordable, only about a few hundred yuan, which has a significant price advantage compared with domestic drugs. It is worth noting that the ingredients of these generic drugs are highly consistent with the original drugs marketed in China.

Dasatinib works by inhibiting the activity of tyrosine kinases. Tyrosine kinase is an enzyme involved in cell growth, differentiation and survival. In leukemia cells, certain tyrosine kinases are abnormally active, leading to abnormal cell proliferation and survival, thus forming leukemia. The mechanism of action of Dasatinib (Startase) is to slow down the proliferation and survival of leukemia cells by inhibiting the activity of these abnormal kinases, thereby controlling the progression of the disease.

Compared with traditional treatment methods, Dasatinib (Startase) has higher selectivity and effect, and can inhibit the growth of leukemia cells more effectively, thus improving the prognosis and survival rate of patients. It is often given as part of long-term treatment and can help patients maintain a stable disease state and reduce the risk of recurrence.

Although dasatinib is excellent at treating leukemia, it may cause some side effects, including nausea, vomiting, diarrhea, fatigue, and edema. Sometimes more serious adverse reactions may occur, such as arrhythmia, bleeding tendency, abnormal liver function, etc. Therefore, when using Dasatinib, doctors usually monitor the patient's specific conditions and adjust the dosage to reduce the occurrence of adverse reactions.